SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-247417
Filing Date
2022-09-20
Accepted
2022-09-20 07:34:54
Documents
14
Period of Report
2022-09-20
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d369218d8k.htm   iXBRL 8-K 27599
2 EX-99.1 d369218dex991.htm EX-99.1 28799
6 GRAPHIC g369218g0920082350437.jpg GRAPHIC 6221
  Complete submission text file 0001193125-22-247417.txt   196646

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wve-20220920.xsd EX-101.SCH 2881
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20220920_lab.xml EX-101.LAB 17927
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20220920_pre.xml EX-101.PRE 11255
8 EXTRACTED XBRL INSTANCE DOCUMENT d369218d8k_htm.xml XML 3326
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 221252078
SIC: 2834 Pharmaceutical Preparations